The Supreme Court today issued notice on a public interest litigation seeking quashing of approvals or licenses granted for manufacturing of 'Liposomal Amphotericin B' for emergency use during the Covid-19 pandemic.The PIL, filed by one Rajendra Prasad, also seeks stoppage of distribution and destruction of existing stock of the said medication, in accordance with appropriate safety protocols....
We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok